Patents by Inventor Benjamin OESTRINGER

Benjamin OESTRINGER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PEPTIDES FROM NPSR1
    Publication number: 20210322528
    Abstract: The present invention relates to novel peptides derived from Neuropeptide S Receptor (NPSR1), complexes comprising such peptides bound to recombinant MHC molecules, and cells presenting said peptide in complex with MHC molecules. Also provided by the present invention are binding moieties that bind to the peptides and/or complexes of the invention. Such moieties are useful for the development of immunotherapeutic reagents for the treatment of diseases such as cancer.
    Type: Application
    Filed: April 29, 2021
    Publication date: October 21, 2021
    Inventors: Alex POWLESLAND, Victoria Arena DE SOUZA, Chandramouli CHILLAKURI, Dhaval SANGANI, Graham HOOD, Benjamin OESTRINGER
  • PEPTIDES DERIVED FROM PROSTATE SPECIFIC ANTIGEN (KLK3) AND COMPLEXES COMPRISING SUCH PEPTIDES BOUND TO MHC MOLECULES
    Publication number: 20210138054
    Abstract: Peptides derived from Prostate specific antigen (KLK3), complexes comprising such peptides bound to recombinant MHC molecules, and cells presenting said peptide in complex with MHC molecules are described. Also provided are binding moieties that bind to the peptides and/or complexes of the invention. Such moieties are useful for the development of immunotherapeutic reagents for the treatment of diseases such as cancer.
    Type: Application
    Filed: November 25, 2020
    Publication date: May 13, 2021
    Inventors: Alex POWLESLAND, Chandramouli CHILLAKURI, Dhaval SANGANI, Graham HOOD, Benjamin OESTRINGER, Pietro DELLACRISTINA
  • PEPTIDES FROM NPSR1
    Publication number: 20180339027
    Abstract: The present invention relates to novel peptides derived from Neuropeptide S Receptor (NPSR1), complexes comprising such peptides bound to recombinant MHC molecules, and cells presenting said peptide in complex with MHC molecules. Also provided by the present invention are binding moieties that bind to the peptides and/or complexes of the invention. Such moieties are useful for the development of immunotherapeutic reagents for the treatment of diseases such as cancer.
    Type: Application
    Filed: November 23, 2016
    Publication date: November 29, 2018
    Inventors: Alex POWLESLAND, Victoria Arena DE SOUZA, Chandramouli CHILLAKURI, Dhaval SANGANI, Graham HOOD, Benjamin OESTRINGER
  • PEPTIDES
    Publication number: 20180339028
    Abstract: The present invention relates to novel peptides derived from Prostate specific antigen (KLK3), complexes comprising such peptides bound to recombinant MHC molecules, and cells presenting said peptide in complex with MHC molecules. Also provided by the present invention are binding moieties that bind to the peptides and/or complexes of the invention. Such moieties are useful for the development of immunotherapeutic reagents for the treatment of diseases such as cancer.
    Type: Application
    Filed: November 23, 2016
    Publication date: November 29, 2018
    Inventors: Alex POWLESLAND, Chandramouli CHILLAKURI, Dhaval SANGANI, Graham HOOD, Benjamin OESTRINGER, Pietro DELLACRISTINA